Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Plus Therapeutics
April 6, 2026
Plus Therapeutics
Orphan Drug Designation
treatment of malignant glioma
Disease Area:
Rare Diseases
Source
Scroll to Top
